Le Lézard
Classified in: Health
Subject: SVY

Neurological Diagnostic Equipments - Medical Devices Pipeline Assessment, 2017



LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary



Download the full report: https://www.reportbuyer.com/product/5134530


GlobalData's Medical Devices sector report, "Neurological Diagnostic Equipments - Medical Devices Pipeline Assessment, 2017" provides an overview of Neurological Diagnostic Equipments currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurological Diagnostic Equipments pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
- Extensive coverage of the Neurological Diagnostic Equipments under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Neurological Diagnostic Equipments and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Neurological Diagnostic Equipments under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/5134530

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com  

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 00:35
WASHINGTON, Oct. 19, 2017 /PRNewswire-USNewswire/ -- In a major victory for public health, the Consumer Product Safety Commission (CPSC) voted today, 3-2, to ban several harmful phthalate chemicals from plastic used in children's toys and child care...

at 00:01
News Canadians can use! The latest in research innovations. Solving complex challenges in heart disease. VANCOUVER, Oct. 19, 2017 /CNW/ - WHAT: Cardiology experts from Canada and around the world converge in...

at 00:01
SAN FRANCISCO, Oct. 19, 2017 /PRNewswire/ -- Common Sense today announced the release of The Common Sense Census: Media Use by Kids Age Zero to Eight, the third installment in an ongoing series of national surveys tracking the use of media and...

at 00:01
PORTLAND, Ore., Oct. 19, 2017 /PRNewswire/ -- People with schizophrenia and bipolar disorder received preventive health screenings at rates similar to or higher than people without mental illnesses, according to a study of more than 800,000 patients...

18 oct 2017
ENGLEWOOD, Colo., Oct. 18, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio") today announced that it has closed it's previously announced registered direct offering of 7,709,400 shares of common stock at a purchase...

18 oct 2017
DENVER, Oct. 18, 2017 /PRNewswire/ -- MassRoots, Inc. (OTCQB:MSRT), one of the leading technology platforms for the cannabis industry, will hold a shareholder conference call hosted by the management team and Isaac Dietrich to discuss the Company's...




News published on 6 october 2017 at 10:30 and distributed by: